Wells Fargo & Company Nevro Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Nevro Corp stock. As of the latest transaction made, Wells Fargo & Company holds 16,624 shares of NVRO stock, worth $75,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,624
Previous 16,532 0.56%
Holding current value
$75,140
Previous $139,000 33.81%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$4.71 - $10.1 $433 - $929
92 Added 0.56%
16,624 $92,000
Q2 2024

Aug 13, 2024
BUY
$7.96 - $13.59 $30,884 - $52,729
3,880 Added 30.67%
16,532 $139,000
Q1 2024

May 10, 2024
BUY
$13.56 - $20.78 $18,482 - $28,323
1,363 Added 12.07%
12,652 $182,000
Q4 2023

Feb 09, 2024
BUY
$14.18 - $22.31 $29,990 - $47,185
2,115 Added 23.05%
11,289 $242,000
Q3 2023

Nov 13, 2023
SELL
$18.22 - $25.85 $104,017 - $147,577
-5,709 Reduced 38.36%
9,174 $176,000
Q2 2023

Aug 15, 2023
BUY
$22.62 - $39.32 $108,100 - $187,910
4,779 Added 47.3%
14,883 $378,000
Q1 2023

May 12, 2023
BUY
$30.17 - $41.11 $261,815 - $356,752
8,678 Added 608.56%
10,104 $365,000
Q4 2022

Feb 13, 2023
SELL
$36.43 - $49.4 $118,943 - $161,291
-3,265 Reduced 69.6%
1,426 $56,000
Q3 2022

Nov 14, 2022
SELL
$40.66 - $53.03 $47,328 - $61,726
-1,164 Reduced 19.88%
4,691 $220,000
Q2 2022

Aug 12, 2022
SELL
$40.85 - $77.67 $270,549 - $514,408
-6,623 Reduced 53.08%
5,855 $257,000
Q1 2022

May 16, 2022
SELL
$59.95 - $92.06 $717,661 - $1.1 Million
-11,971 Reduced 48.96%
12,478 $902,000
Q4 2021

Feb 14, 2022
SELL
$81.07 - $121.29 $345,277 - $516,574
-4,259 Reduced 14.84%
24,449 $1.98 Million
Q3 2021

Nov 15, 2021
SELL
$101.99 - $166.36 $758,499 - $1.24 Million
-7,437 Reduced 20.58%
28,708 $3.34 Million
Q2 2021

Aug 16, 2021
SELL
$141.6 - $179.06 $1.42 Million - $1.8 Million
-10,025 Reduced 21.71%
36,145 $5.99 Million
Q1 2021

May 13, 2021
SELL
$132.81 - $182.18 $1.63 Million - $2.24 Million
-12,297 Reduced 21.03%
46,170 $6.44 Million
Q4 2020

Feb 09, 2021
BUY
$138.17 - $184.34 $1.29 Million - $1.72 Million
9,338 Added 19.01%
58,467 $10.1 Million
Q3 2020

Nov 05, 2020
SELL
$114.09 - $145.51 $2.11 Million - $2.69 Million
-18,486 Reduced 27.34%
49,129 $6.84 Million
Q2 2020

Aug 13, 2020
SELL
$89.45 - $129.85 $1.5 Million - $2.18 Million
-16,787 Reduced 19.89%
67,615 $8.08 Million
Q1 2020

May 14, 2020
BUY
$70.23 - $144.31 $5.93 Million - $12.2 Million
84,402 New
84,402 $8.44 Million

Others Institutions Holding NVRO

# of Institutions
150
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email